Latest article
Zacks: Analysts Count on Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Will Announce Quarterly Gross sales...
Wall Street brokers expect Tandem Diabetes Care, Inc. (NASDAQ: TNDM) to generate revenue of $ 114.67 million in the current fiscal quarter, according to...
ViaCyte Broadcasts Initiation of Section 2 Research of Encapsulated Cell Remedy for Sort 1...
SAN DIEGO, February 3, 2021 / PRNewswire / - ViaCyte, Inc., a clinical-stage regenerative medicine company, announced today that the first patients with...
